338 related articles for article (PubMed ID: 27267049)
1. Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR).
Chaudhuri AA; Binkley MS; Rigdon J; Carter JN; Aggarwal S; Dudley SA; Qian Y; Kumar KA; Hara WY; Gensheimer M; Nair VS; Maxim PG; Shultz DB; Bush K; Trakul N; Le QT; Diehn M; Loo BW; Guo HH
Radiother Oncol; 2016 Jun; 119(3):454-60. PubMed ID: 27267049
[TBL] [Abstract][Full Text] [Related]
2. Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) - An analysis of UK's largest cohort of lung SABR patients.
Saha A; Beasley M; Hatton N; Dickinson P; Franks K; Clarke K; Jain P; Teo M; Murray P; Lilley J
Radiother Oncol; 2021 Mar; 156():153-159. PubMed ID: 33333139
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.
Nakajima N; Sugawara Y; Kataoka M; Hamamoto Y; Ochi T; Sakai S; Takahashi T; Kajihara M; Teramoto N; Yamashita M; Mochizuki T
Ann Nucl Med; 2013 Apr; 27(3):261-70. PubMed ID: 23299492
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Functional Lung Heterogeneity and Dosimetry to Radiation Pneumonitis using Perfusion SPECT/CT and FDG PET/CT Imaging.
Lee HJ; Zeng J; Vesselle HJ; Patel SA; Rengan R; Bowen SR
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1255-1264. PubMed ID: 30108002
[TBL] [Abstract][Full Text] [Related]
5. Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.
Bollineni VR; Widder J; Pruim J; Langendijk JA; Wiegman EM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e551-5. PubMed ID: 22417800
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
[TBL] [Abstract][Full Text] [Related]
7. Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer.
Castillo R; Pham N; Ansari S; Meshkov D; Castillo S; Li M; Olanrewaju A; Hobbs B; Castillo E; Guerrero T
Radiat Oncol; 2014 Mar; 9():74. PubMed ID: 24625207
[TBL] [Abstract][Full Text] [Related]
8. Differences in lung injury after IMRT or proton therapy assessed by
Shusharina N; Liao Z; Mohan R; Liu A; Niemierko A; Choi N; Bortfeld T
Radiother Oncol; 2018 Jul; 128(1):147-153. PubMed ID: 29352608
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer.
Chang JY; Liu H; Balter P; Komaki R; Liao Z; Welsh J; Mehran RJ; Roth JA; Swisher SG
Radiat Oncol; 2012 Sep; 7():152. PubMed ID: 22963661
[TBL] [Abstract][Full Text] [Related]
10. [18F]2-fluoro-2-deoxyglucose positron emission tomography/computed tomography in predicting radiation pneumonitis.
Song H; Yu JM; Kong FM; Lu J; Bai T; Ma L; Fu Z
Chin Med J (Engl); 2009 Jun; 122(11):1311-5. PubMed ID: 19567143
[TBL] [Abstract][Full Text] [Related]
11. Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy.
Liu H; Zhang X; Vinogradskiy YY; Swisher SG; Komaki R; Chang JY
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1017-23. PubMed ID: 22543216
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Ablative Radiation Therapy for Lung Oligometastases: Predictive Parameters of Early Response by
Mazzola R; Fiorentino A; Di Paola G; Giaj Levra N; Ricchetti F; Fersino S; Tebano U; Pasetto S; Ruggieri R; Salgarello M; Alongi F
J Thorac Oncol; 2017 Mar; 12(3):547-555. PubMed ID: 28126325
[TBL] [Abstract][Full Text] [Related]
13. Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy.
Ryckman JM; Baine M; Carmicheal J; Osayande F; Sleightholm R; Samson K; Zheng D; Zhen W; Lin C; Zhang C
Radiat Oncol; 2020 Feb; 15(1):33. PubMed ID: 32054487
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for radiation pneumonitis after stereotactic radiation therapy for lung tumours: clinical usefulness of the planning target volume to total lung volume ratio.
Ueyama T; Arimura T; Takumi K; Nakamura F; Higashi R; Ito S; Fukukura Y; Umanodan T; Nakajo M; Koriyama C; Yoshiura T
Br J Radiol; 2018 Jun; 91(1086):20170453. PubMed ID: 29565649
[TBL] [Abstract][Full Text] [Related]
15. Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [
Yang DM; Palma DA; Kwan K; Louie AV; Malthaner R; Fortin D; Rodrigues GB; Yaremko BP; Laba J; Gaede S; Warner A; Inculet R; Lee TY
Radiat Oncol; 2021 Jan; 16(1):11. PubMed ID: 33441162
[TBL] [Abstract][Full Text] [Related]
16. [18F]-FDG uptake dose-response correlates with radiation pneumonitis in lung cancer patients.
McCurdy MR; Castillo R; Martinez J; Al Hallack MN; Lichter J; Zouain N; Guerrero T
Radiother Oncol; 2012 Jul; 104(1):52-7. PubMed ID: 22578806
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and potential utility of multicomponent exhaled breath analysis for predicting development of radiation pneumonitis after stereotactic ablative radiotherapy.
Moré JM; Eclov NCW; Chung MP; Wynne JF; Shorter JH; Nelson DD; Hanlon AL; Burmeister R; Banos P; Maxim PG; Loo BW; Diehn M
J Thorac Oncol; 2014 Jul; 9(7):957-964. PubMed ID: 24926543
[TBL] [Abstract][Full Text] [Related]
18. Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs.
Bongers EM; Botticella A; Palma DA; Haasbeek CJ; Warner A; Verbakel WF; Slotman B; Ricardi U; Senan S
Radiother Oncol; 2013 Oct; 109(1):95-9. PubMed ID: 24183862
[TBL] [Abstract][Full Text] [Related]
19. Pre-Radiation Therapy Fluorine 18 Fluorodeoxyglucose PET Helps Identify Patients with Esophageal Cancer at High Risk for Radiation Pneumonitis.
Castillo R; Pham N; Castillo E; Aso-Gonzalez S; Ansari S; Hobbs B; Palacio D; Skinner H; Guerrero TM
Radiology; 2015 Jun; 275(3):822-31. PubMed ID: 25584706
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of functionally weighted dose-volume parameters for thoracic stereotactic ablative radiotherapy (SABR) using CT ventilation.
Kanai T; Kadoya N; Nakajima Y; Miyasaka Y; Ieko Y; Kajikawa T; Ito K; Yamamoto T; Dobashi S; Takeda K; Nemoto K; Jingu K
Phys Med; 2018 May; 49():47-51. PubMed ID: 29866342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
